Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Glòria Oliveras

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
BMC Cancer|July 10, 2012
Different fatty acid metabolism effects of (-)-epigallocatechin-3-gallate and C75 in adenocarcinoma lung cancerJoana Relat, Adriana Blancafort, Glòria Oliveras, et al.
Menopause (New York, N.Y.)|August 29, 2013
Fatty acid synthase expression is strongly related to menopause in early-stage breast cancer patientsRut Porta, Adriana Blancafort, Gemma Casòliva, et al.
Oncotarget|November 2, 2017
Fatty acid synthase expression and its association with clinico-histopathological features in triple-negative breast cancerAriadna Giró-Perafita, Ariadna Sarrats, Ferran Pérez-Bueno, et al.
Peptides|August 17, 2010
Antimicrobial cyclic decapeptides with anticancer activityLidia Feliu, Glòria Oliveras, Anna D Cirac, et al.
International Journal of Oncology|June 12, 2012
Androgen-independent prostate cancer cells circumvent EGFR inhibition by overexpression of alternative HER receptors and ligandsDolors Carrión-Salip, Clara Panosa, Javier A Menendez, et al.
International Journal of Molecular Sciences|May 14, 2025
Breast Cancer Stem Cells and Immunogenicity Profile in High-Risk Early Triple-Negative Breast Cancer: A Pilot StudyAriadna Roqué-Lloveras, Ferran Pérez-Bueno, Xavier Pozo-Ariza, et al.
Cancers|February 15, 2022
Epidemiology and Molecular Profile of Mucosal Melanoma: A Population-Based Study in Southern EuropeAnna Carbó-Bagué, Jordi Rubió-Casadevall, Montserrat Puigdemont, et al.
Breast Cancer Research : BCR|December 20, 2011
A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell linesTeresa Puig, Helena Aguilar, Sílvia Cufí, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2016
Preclinical Evaluation of Fatty Acid Synthase and EGFR Inhibition in Triple-Negative Breast CancerAriadna Giró-Perafita, Sònia Palomeras, David H Lum, et al.
Clinical Chemistry|January 23, 2016
Soluble CRTC3: A Newly Identified Protein Released by Adipose Tissue That Is Associated with Childhood ObesityAnna Prats-Puig, Pilar Soriano-Rodríguez, Glòria Oliveras, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
BMC Cancer|July 10, 2012
Different fatty acid metabolism effects of (-)-epigallocatechin-3-gallate and C75 in adenocarcinoma lung cancerJoana Relat, Adriana Blancafort, Glòria Oliveras, et al.
Menopause (New York, N.Y.)|August 29, 2013
Fatty acid synthase expression is strongly related to menopause in early-stage breast cancer patientsRut Porta, Adriana Blancafort, Gemma Casòliva, et al.
Oncotarget|November 2, 2017
Fatty acid synthase expression and its association with clinico-histopathological features in triple-negative breast cancerAriadna Giró-Perafita, Ariadna Sarrats, Ferran Pérez-Bueno, et al.
Peptides|August 17, 2010
Antimicrobial cyclic decapeptides with anticancer activityLidia Feliu, Glòria Oliveras, Anna D Cirac, et al.
International Journal of Oncology|June 12, 2012
Androgen-independent prostate cancer cells circumvent EGFR inhibition by overexpression of alternative HER receptors and ligandsDolors Carrión-Salip, Clara Panosa, Javier A Menendez, et al.
International Journal of Molecular Sciences|May 14, 2025
Breast Cancer Stem Cells and Immunogenicity Profile in High-Risk Early Triple-Negative Breast Cancer: A Pilot StudyAriadna Roqué-Lloveras, Ferran Pérez-Bueno, Xavier Pozo-Ariza, et al.
Cancers|February 15, 2022
Epidemiology and Molecular Profile of Mucosal Melanoma: A Population-Based Study in Southern EuropeAnna Carbó-Bagué, Jordi Rubió-Casadevall, Montserrat Puigdemont, et al.
Breast Cancer Research : BCR|December 20, 2011
A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell linesTeresa Puig, Helena Aguilar, Sílvia Cufí, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2016
Preclinical Evaluation of Fatty Acid Synthase and EGFR Inhibition in Triple-Negative Breast CancerAriadna Giró-Perafita, Sònia Palomeras, David H Lum, et al.
Clinical Chemistry|January 23, 2016
Soluble CRTC3: A Newly Identified Protein Released by Adipose Tissue That Is Associated with Childhood ObesityAnna Prats-Puig, Pilar Soriano-Rodríguez, Glòria Oliveras, et al.
Pageof 2